Mimcina 30 Tablet Substitute
RXLupin Ltd
₹650
(₹58.5 per unit)
RXChemo Healthcare Pvt Ltd
₹653
(₹58.77 per unit)
RXSeptalyst Lifesciences Pvt Ltd
₹654
(₹58.86 per unit)
RXConcord Biotech Ltd
₹661
(₹59.49 per unit)
RXGenix Lifescience Pvt Ltd
₹699
(₹62.91 per unit)
RXHospimax Healthcare Pvt Ltd
₹703
(₹63.27 per unit)
RXPrevego Healthcare & Research Pvt Ltd
₹741
(₹66.69 per unit)
RXAustrak Pvt Ltd
₹748
(₹67.32 per unit)
RXIntas Pharmaceuticals Ltd
₹915.5
(₹82.4 per unit)
RXMerynova Life Sciences India Pvt Ltd
₹995
(₹89.55 per unit)
RXMerynova Life Sciences India Pvt Ltd
₹995
(₹99.5 per unit)
RXPanacea Biotec Ltd
₹7040
(₹577.28 per unit)

Composition:
CINACALCET-30MG
Uses:
Primary hyperparathyroidism, secondary hyperparathyroidism, and Parathyroid cancer.
Medicinal Benefits:
Mimcina 30 Tablet contains 'cinacalcet', which belongs to the class of medications called 'calcimimetics' used in the treatment of primary hyperparathyroidism, secondary hyperparathyroidism, and parathyroid-carcinoma. It works by signalling the body to produce less parathyroid hormone to decrease the amount of calcium in the blood.
Mimcina 30 Tablet works by signalling the body to produce a less parathyroid hormone to decrease the amount of calcium in the blood.
Mimcina 30 Tablet is not recommended for use in patients suffering from chronic kidney disease who are not being treated with dialysis due to the increased risk of hypocalcemia (low blood calcium levels). Replacement with a suitable alternative should be considered based on the clinical condition.
If you have hypotension (low blood pressure) and hypocalcemia (low calcium levels in the blood), please contact a doctor before taking Mimcina 30 Tablet .
Mimcina 30 Tablet should be used with extreme caution in patients suffering from seizures due to the increased risk of worsening their condition. Please consult your doctor before taking Mimcina 30 Tablet .